Category: Interviews
Marco Quarta on Cellular Senescence in Aging
January 24, 2025
Dr. Marco Quarta runs one of the most interesting start-ups in the longevity field: Rubedo, which focuses on utilizing the senolytic approach to cellular senescence. This company has developed ingenious
Cyclarity Launches Human Trial to Cure Atherosclerosis
January 23, 2025
Recently, Cyclarity Therapeutics announced the launch of a Phase 1 human clinical trial for a drug that aims to remove the arterial plaques that lead to heart attacks and strokes.
Why Research Teams Should Email XPRIZE Healthspan Now
December 13, 2024
With the deadline for submissions just around the corner, Jamie Justice, Executive Director of XPRIZE HealthSpan, explains to researchers still on the fence why they should contact her team now
Mehmood Khan on Aging Policy and Collaboration
December 3, 2024
I first met Dr. Mehmood Khan in 2022 at the inaugural Longevity Summit Dublin, where organizers Aubrey de Grey and Martin O’Dea made a bold decision to include policy and
Rozalyn Anderson Explains Caloric Restriction
November 12, 2024
At the University of Wisconsin-Madison, Dr. Rozalyn Anderson is studying one of the oldest-known and yet most powerful anti-aging interventions: caloric restriction (CR). Back in 1935, CR helped launch the
Life Biosciences Is Bringing Reprogramming to the Clinic
October 29, 2024
Life Biosciences is a company co-founded by the celebrity geroscientist David Sinclair and is based on his Harvard team’s research into partial cellular reprogramming. In the heated race to translate
Peter Diamandis: “Stay Healthy, Anti-Aging Tech is Coming”
August 20, 2024
To many people, Peter Diamandis needs no introduction, and to the rest, it’s going to be a long one. To put it as concisely as possible, Peter is a serial
Michael Antonov: from Oculus to Longevity Biotech
August 9, 2024
After Oculus was sold to Facebook for two billion dollars a decade ago, Michael Antonov, one of the founders, could have become a major tech investor, a popular podcaster with
Longevity Biotech Fellowship: Road To A Post-Aging Society
July 16, 2024
The Longevity Biotech Fellowship is one of the most interesting longevity-related initiatives in the last couple of years. Co-founded by Mark Hamalainen and Nathan Cheng, both well-known figures in the
New Gene Therapy Reverses Atherosclerosis In Mice
April 10, 2024
Repair Biotechnologies, a company based in Syracuse, New York, has announced findings from early research suggesting that its technology can quickly stop the advancement of atherosclerosis. While these preclinical results
David Sinclair Hopes Rejuvenation Possible in a Few Decades
March 22, 2024
In this new interview, David Sinclair, Harvard professor and the author of “Lifespan”, explains his theory of aging, shares parts of his health routine, and reveals which directions in today’s
How to Test One Million Molecules
March 19, 2024
Ora Biomedical has created a robot for high-throughput screening of life-extending compounds in worms, and you can buy an experiment for 100 dollars. Things in the longevity field look bright
Solving Atherosclerosis: The Small but Mighty Molecule
February 19, 2024
Cyclarity Therapeutics is developing an affordable, plaque-busting small molecule that may be the cure for the world’s number one killer: cardiovascular disease. With human trials planned for this year, we
Patrick Linden’s Case Against Death
February 12, 2024
People come to the longevity field from all walks of life, bringing their unique expertise along. An activist engages in advocacy and fundraising. A physicist applies theories from a specific
Andrew Steele: “A Mindset Shift Is Required”
January 16, 2024
Andrew Steele is a physicist who became interested in longevity several years ago and began a career as a bioinformatician before becoming a longevity advocate, quickly making a name for
Marco Quarta on Cellular Senescence in Aging
January 24, 2025
Dr. Marco Quarta runs one of the most interesting start-ups in the longevity field: Rubedo, which focuses on utilizing the senolytic approach to cellular senescence. This company has developed ingenious ways to cope with the notorious heterogeneity of senescent cells and is one of the first
Cyclarity Launches Human Trial to Cure Atherosclerosis
January 23, 2025
Recently, Cyclarity Therapeutics announced the launch of a Phase 1 human clinical trial for a drug that aims to remove the arterial plaques that lead to heart attacks and strokes. Tackling the leading cause of death worldwide Cyclarity Therapeutics is working on a cost-effective small molecule
Why Research Teams Should Email XPRIZE Healthspan Now
December 13, 2024
With the deadline for submissions just around the corner, Jamie Justice, Executive Director of XPRIZE HealthSpan, explains to researchers still on the fence why they should contact her team now but also why missing the deadline is not the end of the world. XPRIZE Foundation has
Mehmood Khan on Aging Policy and Collaboration
December 3, 2024
I first met Dr. Mehmood Khan in 2022 at the inaugural Longevity Summit Dublin, where organizers Aubrey de Grey and Martin O’Dea made a bold decision to include policy and advocacy discussions alongside the traditional focus on longevity research. Like many others in the audience, I
Rozalyn Anderson Explains Caloric Restriction
November 12, 2024
At the University of Wisconsin-Madison, Dr. Rozalyn Anderson is studying one of the oldest-known and yet most powerful anti-aging interventions: caloric restriction (CR). Back in 1935, CR helped launch the entire longevity field when a pioneering study by Clive McCay and his colleagues at Cornell University
Life Biosciences Is Bringing Reprogramming to the Clinic
October 29, 2024
Life Biosciences is a company co-founded by the celebrity geroscientist David Sinclair and is based on his Harvard team’s research into partial cellular reprogramming. In the heated race to translate this promising technology to the clinic, Life has emerged as one of the favorites, inching closer
Peter Diamandis: “Stay Healthy, Anti-Aging Tech is Coming”
August 20, 2024
To many people, Peter Diamandis needs no introduction, and to the rest, it’s going to be a long one. To put it as concisely as possible, Peter is a serial entrepreneur and investor in several fields, from commercial space flight to longevity biotech; a visionary speaker
Michael Antonov: from Oculus to Longevity Biotech
August 9, 2024
After Oculus was sold to Facebook for two billion dollars a decade ago, Michael Antonov, one of the founders, could have become a major tech investor, a popular podcaster with his own mega-theory of everything, a hedonist, or all of the above. Instead, he gravitated towards
Longevity Biotech Fellowship: Road To A Post-Aging Society
July 16, 2024
The Longevity Biotech Fellowship is one of the most interesting longevity-related initiatives in the last couple of years. Co-founded by Mark Hamalainen and Nathan Cheng, both well-known figures in the longevity field, LBF has been everywhere: presenting at conferences, participating in co-living projects such as Zuzalu
New Gene Therapy Reverses Atherosclerosis In Mice
April 10, 2024
Repair Biotechnologies, a company based in Syracuse, New York, has announced findings from early research suggesting that its technology can quickly stop the advancement of atherosclerosis. While these preclinical results are in mice, this approach has the potential for treating atherosclerosis in humans. In March, the
David Sinclair Hopes Rejuvenation Possible in a Few Decades
March 22, 2024
In this new interview, David Sinclair, Harvard professor and the author of “Lifespan”, explains his theory of aging, shares parts of his health routine, and reveals which directions in today’s aging research excite him. A professor and a public figure In the longevity field, when it
How to Test One Million Molecules
March 19, 2024
Ora Biomedical has created a robot for high-throughput screening of life-extending compounds in worms, and you can buy an experiment for 100 dollars. Things in the longevity field look bright or gloomy, depending on who you ask. It is true that we now understand much more
Solving Atherosclerosis: The Small but Mighty Molecule
February 19, 2024
Cyclarity Therapeutics is developing an affordable, plaque-busting small molecule that may be the cure for the world’s number one killer: cardiovascular disease. With human trials planned for this year, we decided that it was time to catch up with Cyclarity and its CEO of Scientific Affairs,
Patrick Linden’s Case Against Death
February 12, 2024
People come to the longevity field from all walks of life, bringing their unique expertise along. An activist engages in advocacy and fundraising. A physicist applies theories from a specific domain of knowledge. What happens when a philosopher joins in? Naturally, that person writes a book.
Andrew Steele: “A Mindset Shift Is Required”
January 16, 2024
Andrew Steele is a physicist who became interested in longevity several years ago and began a career as a bioinformatician before becoming a longevity advocate, quickly making a name for himself with numerous media appearances. In 2021, Steele authored Ageless, which we reviewed back then, crowning